MedEdTalks - Gastroenterology
Episodes
Inequities in IBD Research, With Drs. Miguel Regueiro and Kofi Clarke
01 Jul 2025
Contributed by Lukas
In this podcast, expert clinicians discuss barriers to IBD clinical trial participation, including cultural, logistical, and systemic challenges. T...
Overcoming Obstacles to Equitable, Evidence-Based IBD Care, With Dr. Millie Long, Dr. Sandra Quezada, and Ms. Tina Aswani-Omprakash
01 Jul 2025
Contributed by Lukas
In this podcast, expert clinicians and a patient with IBD discuss strategies to ensure equitable, evidence-based care for diverse patient populations....
Racial, Ethnic, and Socioeconomic Disparities in IBD Care With Drs. Millie Long and Edward Barnes
30 Jun 2025
Contributed by Lukas
In this podcast, expert clinicians discuss racial, ethnic, and socioeconomic disparities that have been identified in accessing IBD care, disease mana...
Addressing Barriers to Equitable Inclusion in Clinical Trials, With Dr. Miguel Regueiro, Dr. Neilanjan Nandi, and Ms. Tina Aswani-Omprakash
30 Jun 2025
Contributed by Lukas
In this podcast, expert clinicians and a patient with IBD outline actionable strategies to enhance diversity in clinical trial recruitment and retenti...
Diet and Targeted Therapy With Drs. Dellon and Hirano
19 May 2023
Contributed by Lukas
In this podcast, expert clinicians will discuss diet considerations and targeted therapy for treatment of EoE.
Steroids and PPIs in the Treatment of EoE With Drs. Dellon and Beveridge
19 May 2023
Contributed by Lukas
In this podcast, expert clinicians will discuss the role of steroids and PPIs for treatment of EoE.
Differential Diagnosis of EoE With Drs. Dellon and Chehade
19 May 2023
Contributed by Lukas
In this podcast, expert clinicians will discuss best practices for the differential diagnosis of EoE.
Pearls From the Pros on IBD Management: Anti-Integrin and S1P Receptor Modulation in IBD Practice With Drs. David Rubin and Maria Abreu
06 Jan 2022
Contributed by Lukas
In this podcast, expert clinicians discuss the latest updates on anti-integrin therapy and S1P receptor modulators in IBD management.
Pearls From the Pros on IBD Management: JAK Inhibition in IBD Practice With Drs. David Rubin and Millie Long
06 Jan 2022
Contributed by Lukas
In this podcast, expert clinicians discuss the latest updates on JAK inhibition in IBD management.
Pearls From the Pros on IBD Management: Anti-IL-12/23 in IBD Practice With Drs. David Rubin and Bruce Sands
06 Jan 2022
Contributed by Lukas
In this podcast, expert clinicians discuss the latest updates on anti-IL-12/23 therapy in IBD management.
Pearls From the Pros on IBD Management: Anti-TNF Therapy in IBD Practice With Drs. David Rubin and Stephen Hanauer
06 Jan 2022
Contributed by Lukas
In this podcast, expert clinicians discuss the latest updates on anti-TNF therapy in IBD management.
Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky
18 Aug 2021
Contributed by Lukas
In this podcast, expert clinicians compare the immunogenicity of available biologic therapies and explore options for managing patients who develop an...
Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro
18 Aug 2021
Contributed by Lukas
In this podcast, expert clinicians review the variety of extraintestinal manifestations seen in patients with IBD, discussing strategies for assessmen...
Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky
18 Aug 2021
Contributed by Lukas
In this podcast, experts review appropriate applications of monotherapy and combination therapy and how to position particular therapies based on dise...
New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro
18 Aug 2021
Contributed by Lukas
In this podcast, expert clinicians will discuss the shift from symptom-based management to a treat-to-target paradigm, detailing important treatment a...
Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti
16 Mar 2021
Contributed by Lukas
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage deve...
Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn
16 Mar 2021
Contributed by Lukas
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in l...
Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn's Disease with Drs. William J. Sandborn and Bruce E. Sands
16 Mar 2021
Contributed by Lukas
In this podcast, expert clinicians will discuss emerging therapies with unique mechanisms of action that can improve the treatment of moderate to seve...
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors
29 Apr 2019
Contributed by Lukas
Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's...
Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators
29 Apr 2019
Contributed by Lukas
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's disease, affects an estimated 3 million adults in the United States. Al...
Investigational Agents in Ulcerative Colitis: Anti-Integrins
25 Apr 2019
Contributed by Lukas
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's disease, affects an estimated 3 million adults in the United States. Al...
Ulcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From Copenhagen
25 Apr 2019
Contributed by Lukas
Inflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn's disease, affects an estimated 3 million adults in the United States. Al...